Search

everythinglearnresearchcommunity

for

Search:↓

Many patients experience long-lasting symptoms like fatigue and pain after COVID-19, regardless of initial disease severity.

During the COVID-19 pandemic, a clinic in Turkey saw fewer patients but more cases of certain skin conditions, possibly linked to the virus and stress.

Many COVID-19 survivors continue to experience symptoms like fatigue and concentration problems after recovery, possibly needing rehabilitation.

Recognizing skin symptoms can help diagnose and manage COVID-19.

Early treatment with certain drug combinations improved COVID-19 outcomes and prevented severe disease in males, including those at higher risk.

Patients with long COVID after Omicron had fewer hospitalizations and milder symptoms but more fatigue, insomnia, and cough compared to those with Delta.

Men and women respond differently to drugs for COVID-19, high cholesterol, and diabetes, which suggests a need for personalized treatments.

Passiflora incarnata may help with anxiety and sleep issues but has side effects; teleconsultation for heart failure can improve quality of life; increased screen time for children during the pandemic led to more clinical complaints; older and severely affected COVID-19 patients are more likely to have long-term symptoms.

Pandemic stress worsens hair loss and skin issues, suggesting combined mental and skin care treatments.

COVID-19 infection may trigger alopecia areata in some patients.

Minoxidil helps hair regrow faster in stress-related hair loss.

COVID-19 patients with skin signs often stayed in the hospital for less time than those without skin signs.

Men face more severe COVID-19 outcomes, while women are more likely to have long-term symptoms.

Early hair loss may signal a risk for metabolic syndrome and related health issues.

Passiflora incarnata may help with anxiety but has risks and drug interactions. There's a genetic link between Fragile X Syndrome and Autism Spectrum Disorder. 6.7% of urine cultures showed hospital-acquired urinary tract infections. Children used screens more during COVID-19, causing various health complaints. Autism Spectrum Disorder is often underdiagnosed in females. Dissociative disorders in childhood sexual abuse victims are more common in males. Most pregnant teenagers are not dissatisfied with their body image but worry about weight. Diagnosing tuberculosis after knee surgery is challenging due to non-specific symptoms. Post-COVID-19 syndrome is more common in older, severely affected patients. Psychiatrists should be part of pain management teams due to the psychological aspects of pain.

Testosterone may both worsen and protect against COVID-19 effects in men.

COVID-19 can cause various skin issues, but long-term skin problems are rare.

COVID-19 leaves 80% of patients with long-term symptoms like fatigue and headaches.

Hair loss from COVID-19 usually starts around 45 days after infection and lasts about 47.5 days.

Higher dihydrotestosterone may be linked to more inflammation in COVID-19 patients with low testosterone.

COVID-19 increased hair loss, especially in women, linked to Azithromycin use and symptoms like fatigue and skin irritation.

Covid-19 can cause hair loss due to immune and psychological factors.

A woman's hair loss after COVID-19 was likely due to a mix of pressure-induced alopecia and acute telogen effluvium.

Men have worse COVID-19 outcomes than women due to genetic and hormonal differences.

COVID-19 may affect reproductive and urinary systems, needing more research for better care.

Many recovered COVID-19 patients in Saudi Arabia still experience symptoms like fatigue and anxiety, especially older adults and those with other health issues.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

Hair loss doesn't affect COVID-19 severity.